Durect
18
1
1
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
11.1%
2 terminated/withdrawn out of 18 trials
88.2%
+1.7% vs industry average
28%
5 trials in Phase 3/4
67%
10 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Role: collaborator
A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis
Role: lead
A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment
Role: lead
A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC)
Role: lead
Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis
Role: lead
DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury
Role: lead
An Extension Trial to Evaluate Long-term Safety of SABER™-Bupivacaine for Pain Following Shoulder Surgery
Role: lead
Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain
Role: lead
Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
Role: collaborator
Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
Role: collaborator
Trial of Extended Release Bupivacaine for Pain Relief After Surgery
Role: lead
An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Following Arthroscopic Shoulder Surgery
Role: lead
Bupivacaine Effectiveness and Safety in SABER® Trial
Role: lead
A Safety and Effectiveness Study of SABER®-Bupivacaine for Pain Following Shoulder Surgery
Role: lead
An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Undergoing Hysterectomy
Role: lead
A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair
Role: lead
Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain
Role: lead
Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia
Role: lead
All 18 trials loaded